The frequency of high PD-L1 expression is low in lung adenocarcinoma patients from Northeast Brazil

• Egile Nagusiak: Antonio V. Alves da Silva (Egilea), Francisco Martins Neto (Egilea), Ana Claudia da Silva M. de Oliveira (Egilea), Benedito A. Carneiro (Egilea), Marclesson Alves (Egilea), Cleto Dantas Nogueira (Egilea), Fabio Tavora (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2019-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background As Immune checkpoint inhibitors (ICPIs) are changing the standard-care in lung cancer with good clinical activities and durable responses, its indication must be based on the appropriate patient selection once only a fraction of patients has a response to these costly drugs. In l...